NEW YORK – Uppsala University spinout Readily Diagnostics is using technology built off 30 years of research as the basis of a point-of-care, instrument-free test that would detect and differentiate ...

According to SNS Insider Report, The Rising Demand for Biologics and Cell Therapy Drives Accelerated Growth in the Mycoplasma Testing Market.Austin, May 01, 2025 (GLOBE NEWSWIRE) -- Mycoplasma Testing ...

QIAGEN today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR (dPCR) workflow that now includes solutions for lentivirus-based applications, commonly ...